Dostinex · DIN 02242471 · 0.5 mg · tablet
Limited Use, Reason for Use code 656 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 656 required
Write on scriptReason for Use code 656 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 656
Reason for Use code 656
For the treatment of hyperprolactinemia.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Dostinex · DIN 02242471
Manufacturer: Pharmacia & Upjohn; listing date 2008-06-27
Health Canada: Marketed since 2006-01-05 · brand DOSTINEX · ATC G02CB03 CABERGOLINE · form Tablet · route Oral · ingredients CABERGOLINE 0.5 MG · company Pfizer canada ulc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242471)
Source record
DIN 02242471: Dostinex
Raw flags: sec12=Y, sec3=Y
Item: 920000380; group id 902; item number 2162; lccId 00373; manufacturer id PMJ
Source form: Tab; strength: 0.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $23.5199; ministry $7.2907
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242471
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66198
Interchangeable products
Apo-Cabergoline · DIN 02455897 · $7.2907
Jamp Cabergoline · DIN 02549611 · $7.2907
Shortage status: not checked (no credentials)